EARLY DETECTION

 

There is significant risk in waiting to screen for colorectal cancer (CRC)1


As CRC metastasizes, the 5-year survival rate decreases1,2

Image colorectal cancer diagram

5-year survival rates by stage of CRC1,2*:

Icon up arrow

91%

Stages I, IIa, IIb (Localized)

Icon checkmark

73%

Stages IIc, III (Regional)

Icon checkmark

14%

Stage IV (Distant)


Timely CRC screening and early detection are essential to help reduce mortality rates and potentially save lives3

Icon more than half
Unfortunately, more than half of eligible patients are diagnosed with regional or distant CRC1†
Icon group of people
Many eligible patients with early-stage CRC have no symptoms, making proactive screening the only way to detect CRC4

Discover which patients are eligible for CRC screening with a noninvasive screening method

Despite the ACS lowering its initial screening age to 45 in 20185:

Image 1 in 5 eligible patients

As of 2021, only 1 in 5 eligible patients aged 45 to 49 years reported screening for CRC6

Among eligible patients younger than 50 years, 52% were diagnosed with more advanced CRC vs 40% of patients over the age of 50 years.7‡


  • * Based on people diagnosed with CRC in stage I, stage IIa, or stage IIb between 2013 and 2019.1
  • Based on the percentage of cases diagnosed with CRC in stage II and stage III (38%) and in stage IV (22%).1
  • Data from 2004-2015 from a retrospective study of National Cancer Database.7